DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.04
+0.08 (1.34%)
Apr 30, 2026, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $325.45 million as of April 30, 2026. Its market cap has increased by 114.54% in one year.
Market Cap
325.45M
Enterprise Value
261.49M
1-Year Change
114.54%
Ranking
Category
Stock Price
$6.04
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $325.45M, an increase of 786.79%. That is a compound annual growth rate of 34.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 321.10M | -22.53% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 339.66M |
| Silence Therapeutics | 335.83M |
| Monopar Therapeutics | 335.41M |
| Opus Genetics | 333.45M |
| Bicycle Therapeutics | 329.71M |
| Rezolute | 324.08M |
| Palisade Bio | 323.13M |
| Inhibikase Therapeutics | 317.04M |